Amalgamated Bank Citius Pharmaceuticals, Inc. Transaction History

Amalgamated Bank

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$0.6 - $0.9 $4,381 - $6,572	-7,303 Reduced 63.8%	4,144 $4,000
Q4 2023 Feb 06, 2024	SELL	$0.65 - $0.86 $801 - $1,060	-1,233 Reduced 9.72%	11,447 $9,000
Q2 2023 Aug 11, 2023	BUY	$1.08 - $1.65 $13,694 - $20,922	12,680 New	12,680 $15,000
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.87 $12,083 - $25,676	-13,731 Closed	0 $0
Q1 2022 Jun 30, 2022	SELL	$1.38 - $1.89 $1,454 - $1,992	-1,054 Reduced 7.13%	13,731 $25,000
Q4 2021 Feb 15, 2022	SELL	$1.51 - $2.2 $761 - $1,108	-504 Reduced 3.3%	14,785 $23,000
Q3 2021 Oct 29, 2021	SELL	$1.74 - $2.6 $1,205 - $1,801	-693 Reduced 4.34%	15,289 $31,000
Q2 2021 Aug 16, 2021	BUY	$1.51 - $4.23 $24,132 - $67,603	15,982 New	15,982 $56,000

23.7M

83.1K

32.1K

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $378M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.